Results 101 to 110 of about 5,212 (116)

The costs and benefits of psychedelics on cognition and mood

Neuron, 2023
Frederick S Barrett
exaly  

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review

Journal of Psychopharmacology, 2022
Joost J Breeksema, Jeanine Kamphuis
exaly  

Do psychedelics change beliefs?

Psychopharmacology, 2022
H T Mcgovern, Philip R Corlett
exaly  

Trends in the Top-Cited Articles on Classic Psychedelics

Journal of Psychoactive Drugs, 2021
David Wyndham Lawrence, Roland R Griffiths, Robin L Carhart-Harris   +2 more
exaly  

On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review

ACS Pharmacology and Translational Science, 2021
Richard J Zeifman, Nikhita Singhal, Cory R Weissman   +2 more
exaly  

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

Journal of Neurochemistry, 2022
Urszula Kozlowska, Charles D Nichols, Kalina Wiatr   +2 more
exaly  

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention

Journal of Psychopharmacology, 2022
Rotem Petranker, , Larissa J Maier
exaly  

Reviewing the Potential of Psychedelics for the Treatment of PTSD

International Journal of Neuropsychopharmacology, 2020
Torsten Passie, Eric Vermetten, Passie Torsten   +2 more
exaly  

Serotonergic psychedelics and personality: A systematic review of contemporary research

Neuroscience and Biobehavioral Reviews, 2018
JOSÉ CARLOS Bouso, Rafael G Dos Santos, MIGUEL Angel Alcázar-Córcoles   +2 more
exaly  

The therapeutic potential of microdosing psychedelics in depression

Therapeutic Advances in Psychopharmacology, 2020
Kim P C Kuypers
exaly